Botox® (onabotulinum toxin A) was licensed specifically for the treatment of chronic migraine in July 2010 by the Medicines and Healthcare products Regulatory Agency (MHRA). Botox® has not as yet, been shown to be effective for any other headache type … Continue reading
Thought to affect one in every seven adults, migraine has been recognised by the World Health Organisation as one of the top 20 most disabling lifetime conditions and costs the British economy an estimated £2billion a year. But is migraine … Continue reading
Migraineurs who experienced reduced stress from one day to the next have a significantly higher risk of a migraine attack on the following day, according to a new study published recently in Neurology, the medical journal of the American Academy of … Continue reading